How to Get Metformin in Washington State

What Is Metformin and Why Washington Prescribers Use It

Metformin is a biguanide oral hypoglycemic agent approved by the FDA for type 2 diabetes mellitus in adults and children aged 10 and older, and it is among the most prescribed medications in the United States. Washington clinicians prescribe it as a first-line agent because its 40-year safety record, low cost, and cardiovascular data make it a default starting point for most newly diagnosed patients.

The UKPDS 34 trial (N=1,704 overweight patients with newly diagnosed type 2 diabetes) published in The Lancet in 1998 found that metformin reduced all-cause mortality by 36% and diabetes-related death by 42% compared with conventional diet therapy over a median 10.7-year follow-up [1]. Those figures have anchored prescribing guidelines for over two decades.

The American Diabetes Association's 2024 Standards of Care designate metformin as a preferred initial pharmacologic therapy for type 2 diabetes in the absence of compelling indications for other agents [2]. Washington prescribers follow those same standards. The drug suppresses hepatic glucose production, reduces intestinal glucose absorption, and modestly improves peripheral insulin sensitivity, all without causing hypoglycemia when used as monotherapy [3].

Off-label uses common in Washington practices include polycystic ovary syndrome (PCOS), prediabetes, and weight management adjunct therapy. The Diabetes Prevention Program (DPP) trial (N=3,234) showed metformin 850 mg twice daily reduced progression from prediabetes to type 2 diabetes by 31% over 2.8 years compared with placebo [4]. That evidence base supports its off-label use, though Washington Medicaid (Apple Health) requires prior authorization for the prediabetes indication specifically.

Washington State Prescribing Rules for Metformin

Washington State law permits any licensed prescriber holding an active Washington credential to prescribe metformin. Metformin is a Schedule V-equivalent oral agent (not a controlled substance), which means it carries none of the DEA scheduling restrictions that apply to stimulants or opioids.

Prescribers authorized to write a metformin prescription in Washington include:

• Medical doctors (MD) and osteopathic physicians (DO) licensed by the Washington Medical Commission (WMC)
• Nurse practitioners (ARNP) licensed by the Washington State Nursing Care Quality Assurance Commission, who hold independent prescriptive authority under RCW 18.79.240
• Physician assistants (PA) licensed by the Washington Medical Commission with prescriptive authority
• Certified nurse-midwives (CNM) within their scope of practice

Washington ARNPs have full independent prescriptive authority and do not require physician supervision for routine metformin prescriptions, which broadens access considerably for patients using telehealth platforms.

How to Get a Metformin Prescription in Washington: Step-by-Step

Getting metformin in Washington follows a short, predictable sequence for most patients. The process is rarely longer than one week from first contact to pharmacy pickup.

Step 1. Choose your care pathway. Washington residents can see an in-person primary care physician, endocrinologist, or OB-GYN, or schedule a synchronous telehealth video visit with a Washington-licensed prescriber. Telehealth is fully legal for new and established patients under Washington's telemedicine parity law (RCW 48.43.735) [5].

Step 2. Complete required baseline labs. Before writing a metformin prescription, most Washington clinicians order a comprehensive or basic metabolic panel to establish baseline kidney function (eGFR, serum creatinine) and liver enzymes. The FDA label for metformin contraindications an eGFR below 30 mL/min/1.73 m² and recommends caution when eGFR is 30, 45 [6]. Labs can often be ordered electronically before a telehealth visit so results are available at the time of the appointment.

Step 3. Attend your clinical visit. A standard metformin consultation typically takes 15 to 20 minutes. The prescriber reviews your HbA1c, fasting glucose, weight, kidney function, and any medications that interact with metformin (notably iodinated contrast agents and alcohol).

Step 4. Receive your e-prescription. Washington prescribers transmit prescriptions electronically to any in-state or mail-order pharmacy. Paper prescriptions are still legal but rare. The prescription is typically received by the pharmacy within minutes of the visit ending.

Step 5. Fill at a Washington pharmacy or mail-order service. Standard-release generic metformin 500 mg and 1 to 000 mg tablets are stocked at every major Washington pharmacy chain, including Walgreens, Rite Aid, Bartell Drugs, and Costco. Extended-release formulations (metformin ER, Glumetza, Fortamet) are also widely available.

Telehealth Metformin Prescribing in Washington

Washington State has among the most patient-friendly telehealth laws in the country. A 2020 executive order and subsequent legislative codification require insurers to reimburse telehealth visits at parity with in-person visits, making video consultations financially accessible for most insured Washington residents [5].

For metformin specifically, a telehealth prescriber may:

• Review lab results from an external lab draw ordered before or during the visit
• Prescribe metformin as a new prescription on the same day as a video visit
• Send an e-prescription directly to the patient's preferred pharmacy or mail-order service
• Follow up via asynchronous messaging for dose titration

Washington does not require an in-person visit before telehealth prescribing of metformin because metformin is not a controlled substance. This distinguishes it from stimulants or buprenorphine, which have additional federal requirements. A systematic review in the Journal of the American Medical Association found that telehealth diabetes management produced HbA1c reductions comparable to in-person care, averaging a 0.5% decrease from baseline [7].

Patients using HealthRX's Washington-licensed prescriber network report same-day prescription delivery to their preferred pharmacy in most cases, provided labs are on file before the visit.

Labs Required Before Metformin in Washington

Prescribers order a small set of labs before initiating metformin. None of these tests require a specialist and all are available at Quest, LabCorp, or any Washington hospital outpatient lab.

The core panel includes:

• Serum creatinine and eGFR. The FDA label contraindicates metformin when eGFR is below 30 mL/min/1.73 m² and requires dose review when eGFR falls between 30 and 45 [6]. Patients with eGFR 45 to 60 may start metformin at a reduced dose with closer monitoring.
• Liver function tests (ALT, AST). Metformin is not hepatotoxic but is typically avoided in severe hepatic impairment because impaired lactate clearance raises the theoretical risk of lactic acidosis [8].
• HbA1c and fasting plasma glucose. These confirm the diagnosis of type 2 diabetes (HbA1c 6.5% or above, or fasting glucose 126 mg/dL or above) or prediabetes (HbA1c 5.7 to 6.4%, fasting glucose 100 to 125 mg/dL) per ADA 2024 criteria [2].
• Vitamin B12 (baseline, not always required at initiation). The ADA recommends periodic B12 monitoring because metformin reduces B12 absorption in the terminal ileum over time. The DPP Outcomes Study found a 19% lower B12 concentration in metformin users vs. placebo after 5 years (P<0.001) [9]. Many Washington prescribers check baseline B12 and recheck annually.

A complete metabolic panel (CMP) ordered as a single test covers creatinine, eGFR, ALT, and AST simultaneously, reducing the number of separate orders.

Washington Pharmacy Options and Drug Cost

Generic metformin immediate-release and extended-release tablets are among the least expensive prescription drugs available in Washington. Cash prices as of mid-2025 at major Washington pharmacies are as follows.

A 30-day supply of metformin 500 mg twice daily (60 tablets) runs approximately $4 to $10 at Costco, Walmart, and Fred Meyer pharmacies using their generic programs. The GoodRx price at Seattle-area Walgreens locations is approximately $7 to $14 for the same quantity. Metformin ER 500 mg (60 tablets) costs roughly $10 to $20 cash without a coupon.

Mail-order pharmacies serving Washington, including Amazon Pharmacy and Mark Cuban's Cost Plus Drugs, list metformin 500 mg (90 tablets) for under $8 with free shipping, making them cost-competitive with brick-and-mortar options for patients who want home delivery.

For insured patients, metformin is on Tier 1 of virtually every Washington commercial formulary, meaning the copay is typically $0 to $10 per fill [10].

Washington Apple Health (Medicaid) Coverage for Metformin

Washington Medicaid, called Apple Health, covers metformin for both type 2 diabetes and prediabetes, though the coverage pathways differ by indication.

For type 2 diabetes (ICD-10: E11.x), metformin is covered without prior authorization on the Apple Health preferred drug list. Pharmacy fills process automatically at any participating Washington pharmacy.

For prediabetes (ICD-10: R73.09) or PCOS (ICD-10: E28.2), Apple Health requires prior authorization (PA). The PA process asks the prescriber to document the clinical rationale, relevant lab values, and failure or ineligibility of non-pharmacologic interventions. Most PA requests for metformin in prediabetes are approved within 3 to 5 business days when labs are submitted with the request.

Washington's Health Care Authority publishes the Apple Health preferred drug list and PA criteria at hca.wa.gov. Prescribers can submit PA requests through the ProviderOne portal or via fax. For patients who need immediate access while a PA is pending, most pharmacies can supply a 72-hour emergency supply at no cost under Washington's emergency fill statute.

503A Compounding Pharmacies in Washington

Washington-licensed 503A compounding pharmacies may compound metformin into non-commercially available formulations. This pathway is relevant for patients who need a dose strength not available in standard tablets (for example, a 250 mg capsule for dose titration), a liquid suspension for patients with swallowing difficulties, or a combination formulation for convenience.

503A pharmacies compound for individual patients based on a valid prescription from a Washington-licensed prescriber. They are regulated by the Washington State Department of Health and must comply with USP Chapter 795 standards for non-sterile compounding [11]. The FDA oversees 503A pharmacies at the federal level under Section 503A of the Federal Food, Drug, and Cosmetic Act [12].

Compounded metformin is not interchangeable with FDA-approved generic metformin for insurance billing purposes. Patients typically pay cash for compounded formulations, with costs varying by pharmacy and formulation.

Transferring an Out-of-State Metformin Prescription to Washington

Washington pharmacy law allows the transfer of a valid metformin prescription from another state's pharmacy to a Washington-licensed pharmacy, provided the prescription has remaining refills and has not expired. Federal law (21 CFR Part 1306) governs controlled-substance transfers differently, but metformin, being a non-controlled drug, follows the simpler state pharmacy board rules.

To transfer a prescription, the patient calls their new Washington pharmacy, provides the originating pharmacy name, phone number, and prescription number, and the two pharmacies coordinate the transfer directly. The process takes 24 to 48 hours in most cases. Electronic prescription transfers between pharmacy chains happen faster, often within hours.

One practical note: if the original prescription was written by a prescriber not licensed in Washington, the prescription remains valid for transfer as long as the originating state's prescription is still legally active. The Washington pharmacy honors the original prescriber's order. However, for ongoing refills beyond what the original prescription covers, the patient needs a Washington-licensed prescriber to write a new prescription.

Dosing and Titration Clinicians Use in Washington

Washington prescribers follow the standard titration protocol recommended by the FDA label and ADA guidelines to minimize the gastrointestinal side effects (nausea, diarrhea, bloating) that cause early discontinuation in approximately 5% of patients [2].

Typical initiation:

• Week 1 to 2: Metformin 500 mg once daily with the evening meal.
• Week 3 to 4: Metformin 500 mg twice daily (morning and evening meals).
• Week 5 onward: Titrate by 500 mg per week as tolerated to a target dose of 1,500 to 2 to 000 mg per day in divided doses. The FDA-approved maximum is 2 to 550 mg per day for adults.

Extended-release metformin (metformin ER) taken once daily with the evening meal produces fewer GI side effects than immediate-release twice-daily dosing, based on a randomized trial published in Diabetes Care (N=179) that found significantly lower rates of diarrhea with ER formulations at equivalent doses [13]. Washington prescribers increasingly favor metformin ER as a starting formulation for this reason.

Prior Authorization Documentation in Washington

When prior authorization is required (most often for prediabetes or PCOS indications under Apple Health or certain commercial plans), Washington prescribers submit a PA request that typically includes:

• Patient diagnosis with ICD-10 code
• Most recent HbA1c and fasting glucose values with dates
• Documentation of body mass index, with many plans requiring BMI <45 for prediabetes PA
• Statement that lifestyle intervention alone is inadequate or that the patient meets DPP enrollment criteria
• Prescriber's NPI number and Washington license number

Commercial PA turnaround in Washington averages 3 to 7 business days for non-urgent requests. Urgent PA designations (clinically urgent need) must be adjudicated within 72 hours under Washington's insurance code (RCW 48.43.535) [14].

Patients denied PA have the right to appeal. The Washington Office of the Insurance Commissioner provides a free independent medical review process for denied PA requests, and overturning a denial for metformin in prediabetes is common when ADA-aligned clinical documentation is submitted.

Side Effects Washington Prescribers Monitor

Metformin's safety profile is well characterized. The most common adverse effects are gastrointestinal and dose-dependent: nausea, diarrhea, and abdominal discomfort affect up to 30% of initiators but resolve in most patients within 4 to 8 weeks of consistent use [3].

Lactic acidosis is the most serious labeled risk, though it is rare with current prescribing standards. A Cochrane review (Salpeter et al., 2010) found no confirmed cases of metformin-associated lactic acidosis in over 36,000 patient-years of exposure when patients with eGFR below 30 were excluded [15]. Washington prescribers use kidney function screening to keep patients within safe prescribing parameters.

Metformin should be held for 48 hours around iodinated contrast procedures because contrast can transiently reduce kidney function. The American College of Radiology guideline recommends holding metformin at the time of contrast administration and restarting after 48 hours if kidney function remains stable [16].

Long-term use reduces vitamin B12 levels in a subset of patients. The ADA 2024 Standards recommend checking B12 periodically in patients on long-term metformin, particularly those with peripheral neuropathy or who consume little dietary B12 [2].